Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPTN
5101
DELISTED
Cepton, Inc. Common Stock
CPTN
| $175K | ﹤0.01% |
+36,163
| New | +$159K |
|
5102
Shattuck Labs
STTK
$794M
| $175K | ﹤0.01% |
56,180
-3,100
| -5% | -$8.99K |
|
5103
Tilray
TLRY
$641M
| $175K | ﹤0.01% |
+11,286
| New | +$242K |
|
5104
Heritage Global
HGBL
$42.6M
| $174K | ﹤0.01% |
+48,192
| New | +$159K |
|
5105
Voyager Therapeutics
VYGR
$214M
| $174K | ﹤0.01% |
15,220
-1,147,333
| -99% | -$11.9M |
|
5106
PUT
First Majestic Silver
AG
$10.4B
| $174K | ﹤0.01% |
+30,800
| New | +$197K |
|
5107
CALL
Qfin Holdings
QFIN
$1.15B
| $173K | ﹤0.01% |
+10,000
| New | +$168K |
|
|
5108
PUT
Qfin Holdings
QFIN
$1.15B
| $173K | ﹤0.01% |
+10,000
| New | +$168K |
|
|
TECX
5109
Tectonic Therapeutic
TECX
$714M
| $173K | ﹤0.01% |
15,133
+505
| +3% | +$5.71K |
|
|
AEVA
5110
Aeva Technologies
AEVA
$1.1B
| $172K | ﹤0.01% |
27,556
+7,124
| +35% | +$40.6K |
|
5111
Aligos Therapeutics
ALGS
$46.9M
| $171K | ﹤0.01% |
7,035
-9,100
| -56% | -$244K |
|
5112
CION Investment
CION
$362M
| $170K | ﹤0.01% |
16,416
-27,309
| -62% | -$269K |
|
|
ISPO
5113
DELISTED
Inspirato
ISPO
| $170K | ﹤0.01% |
+8,694
| New | +$157K |
|
|
HLTH
5114
DELISTED
Cue Health Inc. Common Stock
HLTH
| $168K | ﹤0.01% |
+456,544
| New | +$390K |
|
|
OSG
5115
Octave Specialty Group
OSG
$204M
| $168K | ﹤0.01% |
11,820
-100,546
| -89% | -$1.47M |
|
|
BASE
5116
DELISTED
Couchbase
BASE
| $168K | ﹤0.01% |
10,632
-6,207
| -37% | -$101K |
|
5117
Old National Bancorp
ONB
$9.89B
| $167K | ﹤0.01% |
11,991
-749,019
| -98% | -$9.96M |
|
|
HLLY.WS
5118
CALL
DELISTED
Holley Inc Warrants
HLLY.WS
| $167K | ﹤0.01% |
333,333
| – | – |
|
5119
Battalion Oil
BATL
$75M
| $166K | ﹤0.01% |
+29,135
| New | +$193K |
|
|
DFTX
5120
Definium Therapeutics
DFTX
$5.99B
| $166K | ﹤0.01% |
+46,553
| New | +$161K |
|
5121
CALL
Archer Aviation Redeemable Warrants
ACHR.WS
$7.68M
| $166K | ﹤0.01% |
202,466
| – | – |
|
|
TPC
5122
Tutor Perini Cor
TPC
$4.6B
| $166K | ﹤0.01% |
23,180
-38,848
| -63% | -$232K |
|
5123
Hamilton Beach Brands
HBB
$437M
| $165K | ﹤0.01% |
+17,033
| New | +$170K |
|
|
RNWWW
5124
CALL
DELISTED
ReNew Energy Global PLC Warrant
RNWWW
| $164K | ﹤0.01% |
205,559
+5,936
| +3% | +$4.63K |
|
|
HITI
5125
High Tide
HITI
$224M
| $164K | ﹤0.01% |
132,001
-53,544
| -29% | -$69.5K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.